01. A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection. Katharina A. Mayer et al. NEJM 2024.
02. Mechanism and treatment for chronic antibody-mediated rejection in kidney transplant recipients. Hajime Sasaki et al. International Journal of Urology (2023).
03. Post-Transplant Surveillance and Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Patients in Europe
Lionel P. E. Rostaing et al. Transplant international 2023.
04. Capillary deposition of C4d complement fragment and early renal graft loss. H E Feucht et al. Kidney Int. 1993.